Drugs Made In America Acquisition II Corp. is a blank-check (SPAC) company formed to complete a business combination with one or more operating businesses. Its stated focus is evaluating targets in the pharmaceutical sector, consistent with a theme of U.S.-oriented drug manufacturing and related activities. Until a deal closes, it has no significant commercial operations and holds proceeds primarily in trust.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 0 | — | -0.1 | — |
| Q2 2025 | 0 | — | -0 | — |
| Q3 2025 | 0 | — | -0.1 | — |
| Q4 2025 | 0 | — | 4.3 | — |
| Q1 2026 | 0 | — | 4.3 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: OIO Group (OIO), CorMedix Inc. (CRMD), Vinci Compass Investments Ltd. (VINP), Aquestive Therapeutics, Inc. (AQST), Village Super Market, Inc. (VLGEA), Kearny Financial Corp. (KRNY)